Left Main Stenting (n=51) | |||
---|---|---|---|
Endpoints | 1-vessel disease (n=29) | 2 or 3-vessel disease (n=22) | Log rank p-value |
Subsequent 2 Year Survival | 82.8% | 71.4% | 0.495 |
Subsequent 2 Year Freedom from Myocardial Infarction | 86.2% | 81.8% | 0.699 |
Subsequent 2 Year Freedom from Further Deterioration in LV Function | 69.0% | 63.6% | 0.847 |